Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up investigation for PPHN patients treated with sildenafil
2010-021266-30Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sildenafil in persistent pulmonary hypertension of the newborn (PPHN), sponsored by Pfizer. Primary endpoint: Physical and neurodevelopmental examination at 12 and 24 months. Started Oct 2011; status: completed.
02
Drugs
sildenafil
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on 2010-021266-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021266-30.